missing translation for 'onlineSavingsMsg'
Learn More

Ki67/MKI67 Antibody (CL1234) [PerCP], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-76476PCP

Product Code. 30299958

  • 737.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Ki67/MKI67 Monoclonal antibody specifically detects Ki67/MKI67 in Human samples. It is validated for Immunohistochemistry,Immunohistochemistry (Paraffin),Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Ki67/MKI67
Monoclonal
PerCP
antigen identified by monoclonal Ki-67, antigen KI-67, Antigen Ki67, Ki67, Ki-67, KIA, Marker Of Proliferation Ki-67, MIB-, MIB-1, PPP1R105, Proliferation Marker Protein Ki-67, proliferation-related Ki-67 antigen, Protein Phosphatase 1, Regulatory Subunit 105
This antibody was developed using a recombinant protein derived from P46013, with the exact immunogen sequence remaining proprietary.
0.1 mL
Breast Cancer, Cancer, Cell Biology, Cell Cycle and Replication, Cellular Markers, Chromatin Research, Mitotic Regulators, Neuroscience
4288
Store at 4⪚C in the dark.
IgG1
Immunohistochemistry, Immunohistochemistry (Paraffin), Immunocytochemistry/Immunofluorescence
CL1234
PBS
Mouse
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.